Pharmaceutical Law Insight
US court wants clarification on pay-to-delay settlements
The US Court of Appeals has called on the District Court to revisit a 2005 decision which set the legal precedent to allow
so-called ‘pay-to-delay’ deals within the pharmaceutical industry.